Wednesday, November 3, 2010

NNVC - Buy Signal

For what seems like an eternity, NNVC has been on a Daily Sell Signal.  Things look to be changing today:

NNVC Daily Trend Model

If NNVC closes today above $1.08 it will generate its first Buy signal since August.  Although not perfect, these Buys on NNVC have been very good, some leading to excellent returns.

On the fundamental side, here is a recent quote from Patrick Cox who writes, Breakthrough Technology Alert:

NanoViricides is on the precipice of a mammoth breakthrough — they hold what is likely the cure to all worldly viruses.  In combination with that, NanoViricides holds a virtual license to profit through the FDA voucher system.

Best of all, the story hasn’t hit the mainstream media yet and your opportunity to join this transformational move is still here.

Incidentally, we know that small biotechs are particularly subject to irrational vacillations. It’s inevitable that this company will be bouncing in weeks and months to come. Right now, however, almost nobody knows what I’ve said in this report. If you plan to buy, be patient and pick up stock when prices are down.

If you jump in and bid the price of this small cap up too high, it will attract attention and the bargains could be gone for good. And please don’t settle for short-term gains of a few hundred percent. The long-run potential of this technology is far, far greater — and today’s opportunity truly is once in a lifetime.

Back when NNVC was under $0.50 I suggested that buying $10,000 worth of NNVC will be worth $1,000,000 by 2014.  Development of the company's anti-viral platform in the past year is consistent with that forecast.  If anything, I am way low as NNVC is getting ready to become front page news in every medical journal across the world.  Again from Patrick Cox:

Next on the list is HIV. Back in 2008, spectacular results were announced for HIVCide in Israel. Based on the findings there, it was suggested that the company had attained a “functional cure.” This is due to the drug’s ability to decrease the amount of circulating virus and to suppress the virus exiting infected cells in which it was sequestered. HIVCide should allow an affected person to live an essentially normal life, as virus load is so low that the virus cannot be transmitted.

Want to put a price on the worth of an antiviral that conquers HIV?

Even I am not so bold.


A